Epidemiology, Risk Factors for Stroke, and Management of Atrial Fibrillation in China

Journal of the American College of Cardiology

Volumn 52, Issue 10, 2008, Pages 865-868

  Hu, Dayi ^a   Sun, Yihong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

anticoagulation; atrial fibrillation; epidemiology; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; THROMBIN INHIBITOR; WARFARIN;

BLEEDING; CEREBROVASCULAR ACCIDENT; CHINA; DISEASE ASSOCIATION; EDITORIAL; EPIDEMIC; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; STROKE; THROMBOEMBOLISM;

ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; CHINA; HUMANS; INCIDENCE; PLATELET AGGREGATION INHIBITORS; RISK; RISK FACTORS; STROKE; THROMBOEMBOLISM; WARFARIN;

EID: 49949119398     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.042     Document Type: Editorial

References (9)

1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991) 983-988
2. Zhou Z., Hu D., Chen J., et al. An epidemiological survey of atrial fibrillation in China. Chin J Intern Med 43 (2004) 491-494
3. Hu D., Sun Y., and Zhou Z. Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study. Chin J Intern Med 42 (2003) 157-161
4. Qi W.-H. Society of Cardiology, Chinese Medical Association. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China. Int J Cardiol 105 (2005) 283-287
5. Fuster V., Ryden L.E., Cannon D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) e149-e246
6. Sun Y., and Hu D. The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese. Chin J Intern Med 43 (2004) 258-260
7. Hu D., Zhang H., Sun Y., et al. The randomized study of efficiency and safety of antithrombic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin. Chin J Cardiol 34 (2006) 295-298
8. AF Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
9. Hirsh J., Fuster V., Ansell J., and Halperin J.L. American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol 41 (2003) 1633-1652